Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / CL A
-
Number of holders
-
210
-
Total 13F shares, excl. options
-
22,488,662
-
Shares change
-
+315,734
-
Total reported value, excl. options
-
$3,246,552,389
-
Value change
-
+$17,443,037
-
Put/Call ratio
-
43%
-
Number of buys
-
106
-
Number of sells
-
-103
-
Price
-
$144.34
Significant Holders of REATA PHARMACEUTICALS INC - CL A (RETA) as of Q1 2020
271 filings reported holding RETA - REATA PHARMACEUTICALS INC - CL A as of Q1 2020.
REATA PHARMACEUTICALS INC - CL A (RETA) has 210 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 22,488,662 shares
.
Largest 10 shareholders include CPMG Inc (3,063,567 shares), WELLINGTON MANAGEMENT GROUP LLP (3,020,924 shares), VANGUARD GROUP INC (2,239,728 shares), BlackRock Inc. (2,123,379 shares), FRANKLIN RESOURCES INC (1,201,871 shares), PRICE T ROWE ASSOCIATES INC /MD/ (947,136 shares), FMR LLC (726,370 shares), Duquesne Family Office LLC (531,878 shares), STATE STREET CORP (518,165 shares), and Cormorant Asset Management, LP (487,206 shares).
This table shows the top 210 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.